Source: Rachel Aiello, CTV News, October 2, 2018
OTTAWA — As trade experts look deeper into what exactly Canada signed onto as part of the United States-Mexico-Canada Agreement, questions are arising about what the new trade deal will mean for drug costs, and whether or not Canada just tied its hands when it comes to trade diversification.
The trilateral deal will replace NAFTA once all three countries’ legislatures approve and ratify the wide-spanning agreement, which took 14 months of renegotiation.
The new deal includes a chapter that has raised the eyebrows of some trade experts, and critics of the federal Liberal government.
Image Source: THE CANADIAN PRESS/Sean Kilpatrick
